鲁抗医药：头孢呋辛酯干混悬剂通过仿制药一致性评价

Core Viewpoint - The company has received approval from the National Medical Products Administration for the drug Cefuroxime Axetil dry suspension, which has passed the consistency evaluation of generic drug quality and efficacy [1] Group 1: Product Information - Cefuroxime Axetil is a prodrug of Cefuroxime and belongs to the second generation of cephalosporin antibiotics, which work by inhibiting bacterial cell wall synthesis, preventing bacterial reproduction [1] Group 2: Research and Development - The company has invested approximately 12.82 million RMB (1.282 million) in research and development for the consistency evaluation of this drug since the initiation of the project [1]